| Authors: |
Martin de Fourchambault E; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U 1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Callens N; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U 1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Saliou JM; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UAR CNRS 2014 - US Inserm 41 - PLBS, Lille, France., Fourcot M; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UAR CNRS 2014 - US Inserm 41 - PLBS, Lille, France., Delos O; MetaToul-MetaboHUB, National Infrastructure of Metabolomics and Fluxomics, Toulouse, France.; I2MC, Université de Toulouse, Inserm, Université Toulouse III - Paul Sabatier (UPS), Toulouse, France., Barois N; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U 1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France.; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UAR CNRS 2014 - US Inserm 41 - PLBS, Lille, France., Thorel Q; Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, France., Ramirez S; Faculty of Health and Medical Sciences, Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital Hvidovre and Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Bukh J; Faculty of Health and Medical Sciences, Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital Hvidovre and Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Cocquerel L; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U 1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Bertrand-Michel J; MetaToul-MetaboHUB, National Infrastructure of Metabolomics and Fluxomics, Toulouse, France.; I2MC, Université de Toulouse, Inserm, Université Toulouse III - Paul Sabatier (UPS), Toulouse, France., Marot G; Université de Lille, Inria, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Lille, France., Sebti Y; Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, France., Dubuisson J; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U 1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France., Rouillé Y; Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U 1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France. |
